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Abstract 
HM-1 killer toxin secreted from Hansenula mrakii inhibits the growth of Saccharomyces cerevisiae cells by interfering with/%l,3-glucan synthesis. 
We found that HM-1 killer toxin killed intact cells but not nrotoolasts. In addition. cells lacking the functional KRE6 allele (kre6d) became resistant 
to higher concentration of HM-1 killer toxin. As reported by Xoemer and Bus$ey [(1991) I%oc. Natl. Acad. Sci. 88 112&-l li99], cells lacking 
functional KRE6 had a reduced level of the cell wall j?-1,6-glucan compared to that in cells harboring the normal KRE6. These results suggest hat 
the cell wall /3-&can is involved in the action of HM-1 killer toxin. Addition of HM-1 killer toxin with several kinds of olieosaccharides revealed 
that either &l,j- or /3-1,6-glucan blocked the cytocidal action of HM-1 killer toxin whereas a-1,4-glucan and chitin did not. Gannan also interfered 
with HM-1 killer toxin action, but this inhibitory effect was much weaker than that observed with/L1,3- or B-1,6-glucans. Thus, it appears that the 
cell wall B-glucan interacts with HM-1 killer toxin, and that this toxin+glucan commitment is required for the action of HM-1 killer toxin. 
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1. Introduction 
HM-I killer toxin is a polypeptide secreted from the 
yeast, Hansenula mrakii, and kills sensitive strains of 
yeast presumably by interfering with the synthesis of 
/I-1,3-glucan while not affecting the synthesis of DNA, 
RNA, protein and lipid [2]. This toxin consists of 88 
amino acids, of which 10 are cysteines [3], and is inac- 
tivated by reducing reagents uch as 2-mercaptoethanol 
and dithiothreitol, demonstrating that S-S bonds are 
essential for the biological activity of HM-1 killer toxin 
PI. 
The detailed mechanism underlying the action of 
HM-1 killer toxin is still not well understood. However, 
we have recently isolated the Saccharomyces cerevisiae 
gene, the over-expression of which gave rise to a pheno- 
type resistant to this toxin [4]. This gene, designated as 
HKRI (~ansenula killer toxinresistant gene lJ, contains 
an open reading frame which can encode a serine- and 
threonine-rich type 1 membrane protein. The existence 
of a consensus equence of the calcium-binding sites (EF- 
hand motif) in Hkrlp suggests that the calcium-binding 
cell surface protein is involved in the action of HM-1 
killer toxin. 
In contrast, Kl killer toxin of S. cerevisiae has an 
affinity to the linear p-1,6-glucan polymer [5,6], and the 
binding of Kl killer toxin to the cell wall B-1,6-glucan is 
the initial step for the action of this toxin [5,6]. Several 
genes responsible for cell wall j&1,6-glucan synthesis 
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have been isolated with kre mutants in which the cell wall 
/I-1,6-glucan content is significantly reduced and, there- 
fore, the mutants become resistant to Kl killer toxin 
[1,7-121. These genes are designated as KRE genes, and 
introduction of KRE genes into kre mutants results in the 
production of normal levels of /?-1,6-glucan. KRE6, one 
of the KRE genes, is considered to be involved in both 
P-196-9 and /I-1,3-glucan synthesis [l]; disruption of 
KRE6 results in the reduction of the /3- 1,6-glucan content 
of the cell wall as well as /?-1,3-glucan synthase activity 
VI. 
In order to study the mechanism of action of HM-1 
killer toxin, we examined the interaction of the cell wall 
polysaccharides with HM-1 killer toxin. Here, we report 
the resistance of yeast cells lacking a functional KRE6 to 
HM-1 killer toxin, and the possible interaction of HM-1 
killer toxin with the cell wall &glucan. 
2. Materials and methods 
2. I. Purification of HM-I killer toxin 
HM-1 killer toxin was purified from the culture medium of 
Hansemda mrakii (IF0 0895) as described [3,4]. The purified HM-1 
killer toxin killed S. cerevisiae A451 (a can1 leu2 trpl ura3 aro7) cells 
at a concentration of 1 &ml or higher. 
2.2. Cloning of KREb 
KREd was cloned by means of PCR and subsequent screening of the 
yeast genomic DNA library with a PCR product as a probe. Primers 
used for PCR were 5’-CTAACTGAAACGCACAAC-3’ and 5’- 
CAACGGATATAACCATTGTC-3’, and genomic DNA of S. cere- 
visiae (strain YNN295) (purchased from Clontech) was used as the 
template DNA. PCR was performed with 25 cycles of the serial reac- 
tions including incubation at 92°C for 1 min (for denaturation), at 55°C 
for 2 min (for annealing) and at 72°C for 3 min (for elongation). The 
PCR product, which was about 1.5 kb long, was fractionated on an 
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2.8. Competition of HM-I killer toxin with oligosaccharides 
Cells of strain A451 (a, canl, leu2, trpl, ura3, aro7) grown to the early 
logarithmic phase in YPD medium were harvested and suspended in 
H,O. About 4000 cells in 100 ~1 H,O were incubated with 1.5 ,ug/ml 
HM-1 killer toxin and various concentrations of oligosaccharides at 
30°C for 3 h with shaking, and then they were spread on the YPD agar 
plates. After incubation at 30°C for 3 days, the number of colonies that 
had appeared on the plates were counted. 
agarose gel, purified from the gel, radiolabelled with [“P]dCTP, and 
used as a probe for screening the yeast genomic DNA library [13]. The 
library was screened under stringent conditions (5 x SSC, 1 x Den- 
hardt’s solution, 20 mM sodium phosphate buffer (pH 6.5), 0.1% SDS 
and 50% formamide at 42°C for the hybridization, and 0.1 x SSC and 
0.1% SDS at 60°C for washing). Construction of the yeast genomic 
DNA library was as described [4]. 
2.3. Generation of kre6A null mutant and re-introduction of KRM 
The kre6Anull mutants were generated by single-step gene disruption 
[14]. The 1.3 kb EcoRI-EcoRI region of the KRE6 gene was replaced 
with a LEU2 cassette [15]. Transcriptional direction of the LEU2 gene 
was made to be opposite to that of KRE6. The diploid yeast strain 
RAY3A-D (ala ura3/ura3 leu2fleu2 his3/his3 trpl/trpl), was trans- 
formed with the resulting HKRI-LEU2 chimeric gene, and several 
leucine prototrophs were collected, allowed to sporulate, and subjected 
to tetrad dissection. In order to introduce KRE6 into the kre6A null 
mutant strain, a 6.6 kb ClaI-BamHI fragment of yeast genomic DNA, 
which contained the entire KRE6 together with its own promoter, was 
subcloned at the BamHI cleavage site of pRS416, a vector carrying the 
centromeric replication origin and URA3 as a selectable marker. Trans- 
formation of the yeast cells was carried out using alkali cation as 
described [16]. 
2.4. Southern blotting 
In order to confirm that the chimeric KRM-LEU2 gene was inte- 
grated at the expected locus, genomic DNA was extracted from the 
oarental RAY3A-D cells. the leucine Drototroohic RAY3A-D cells, 
and the cells derived fro& the spores aft& tetrad-dissection. Thereafter 
the DNA was digested with EcoRI, fractionated on an agarose gel, 
transferred to a nylon membrane, hybridized with the radiolabelled 
probe, and visualized by autoradiography 1131. The probe used for 
Southern blotting was a 1.3 kb EcoRI-EcoRI fragment of the cloned 
KRE6. Conditions for hybridization and washing the filters were the 
same as those for screening the genomic DNA library. 
2.5. Assay for the resistance to HM-1 killer toxin 
Haploid cells of RAY3A-D (KRE6), those of the kre6A null mutant 
(kre6A:: LEU2) and the kre6A null mutant which was transformed with 
a plasmid harboring intact KRE6, were grown in synthetic dextrose 
(SD) medium supplemented with required amino acids. These cells were 
harvested at the early logarithmic phase, and about 1000 cells were 
inoculated into 150~1 of SD medium containing various concentrations 
of HM-1 killer toxin. In some experiments, a sorbitol(1 M)-containing 
medium was also used for culturing the cells. After culturing cells at 
30°C for 2 days, growth of the cells was monitored by measuring the 
ODm of the cell suspension. 
2.6. Fractionation and analysis of the cell wall glucan 
Cell wall polysaccharides were fractionated by the method reported 
by Manners et al. [17] and Peat et al. [18] with some modifications. 
Lyophilized yeast cells grown to late logarithmic phase in YPD medium 
were autoclaved for 90 min at 120°C. The insoluble residues were 
collected by centrifugation, and extracted 4 times with 1.0 N NaOH 
containing 0.5% NaBH, for a total of 24 h at 30°C with gentle shaking. 
After centrifugation, the supernatant fractions containing alkali-solu- 
ble glucans were combined, neutralized with acetic acid, dialysed 
against H,O and lyophilized. The precipitates were also neutralized and 
extracted 5 times with 0.5 N acetic acid at 90°C for 90 min. The acid 
insoluble glucans were centrifuged, dialysed against H,O, and lyophil- 
ized. Fractionated glucans were methylated as described [19]. This step 
was repeated twice, and then methylated glucans were hydrolyzed with 
2 M trifluoro acetic acid for 2 h at 110°C and acetylated as described 
1201. The partially methylated alditol acetates were analysed by gas 
liquid chromatography using a glass column (130 x 0.3 cm) of 3% 
OV210 on Suplecoport at 180°C with a nitrogen flow rate of 15 ml/min. 
2.7. Preparation of poly- and oligosaccharides 
Chitin oligosaccharide was purchased from Seikagaku Kogyo 
(Tokyo). Laminaran and soluble starch were purchased from Nakarai 
Tesque (Kyoto). Short-chain pachyman (D.P. = 20), yeast cell wall 
mannan and /3-1,6-glucan (psutulan) were prepared according to the 
method of Ogura et al. [21], Peat et al. [22] and Lindberg et al. 1231, 
respectively. 
3. Results 
Since HM-1 killer toxin is a secreted protein, it is 
conceivable that HM-1 killer toxin acts on the outside 
the cells by interacting with cell surface components, 
especially with those in the cell wall. To address this 
possibility, effects of HM-1 on protoplasts were exam- 
ined. S. cerevisiae A451 cells were treated with zymolyase 
and the resulting protoplasts were incubated in YPD 
medium containing 1 M sorbitol and various concentra- 
tions of HM-1 killer toxin. Incubation of the intact cells 
with 6 pg/ml HM-1 killer toxin for 3 h resulted in the 
death of more than 95% of the intact cells whereas the 
protoplasts were not killed by the same treatment: the 
HM-1 killer toxin induced the lysis of the normal cells 
during the toxin treatment. Protoplasts did not divide in 
the presence of HM-1 killer toxin, but they survived and 
started cell division after they were transferred to toxin- 
free medium (data not shown). These results strongly 
suggest an interaction of HM-1 killer toxin with cell wall 
components. 
Next, we examined the possibility that HM-1 killer 
toxin interacts with cell wall B-glucans because B-glucan 
is a major component of the yeast cell wall. Since KRE6 
is known to be a gene involved in cell wall /3-glucan 
biosynthesis [l], we cloned the KRE6 gene from a yeast 
genomic DNA library, and generated kre6A null mutants 
by disrupting KRE6. The cloned KRE6 had 6 nucleotide 
substitutions when compared to that reported by 
Roemer and Bussey [l]; C for G at positions 992 and 
2041, G for C at 930, 970 and 1014, T for G at 1448 
(position 1 corresponds to the first A in the translation 
initiation codon in the open reading frame). Nucleotide 
substitutions at positions 992,930, 1448 and 2041 would 
also result in the amino acid substitutions of His33’ for 
Asp, G1u310 for Asp, Vars3 for Gly and Gln6” for Glu, 
respectively. Two thirds of the coding region of KRE6 
was replaced with the LEU2 gene (Fig. lA), and cells 
with a disrupted KRE6 allele were confirmed by South- 
ern blotting. As shown in Fig. lB, two clones from the 
dissected spores, 342 and 343, had a normal KRE6 allele 
(KREQ, but the other two clones, 341 and 344, harbored 
only the KRE6-LEU2 chimeric allele (kre6A:: LEU2). 
Cells from kre6A:: LEU2 lines showed slower growth and 
a reduced level of /3-glucan synthase activity compared 
to those of cells from KRE6 lines (not shown), and this 
was consistent with the results of Roemer and 
Bussey [l]. 
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Fig. 1. Disruption of KRE6 (A) A 1.3 kb EcoRI-EcoRI region of KRE6 was replaced with LEV2. The diploid yeast strain, RAY3A-D, was 
transformed with the resulting KRE6-LEV2 chimeric DNA, and leucine prototrophs were allowed to sporulate and were subjected to tetrad dissection. 
(B) Southern blotting of the DNA from offsprings of each spore. Genomic DNA was digested with EcoRI, and hybridized with a radiolabelled 
1.3 kb EcoRI-EcoRI fragment of KRE6. Bands corresponding to normal KRE6 and chimeric KRE6-LEV2 DNA are indicated by arrowheads. 
Cells of the KRE6 lines remained sensitive to HM-1 
killer toxin; 1 pg/ml HM-1 killer toxin nearly completely 
inhibited the growth of the cells. In contrast, cells from 
the kre6A::LEU2 lines were resistant to higher concen- 
trations of HM- 1 killer toxin. The MIC (minimum inhib- 
itory concentration) of HM-1 killer toxin for KRE6 and 
for kre6A::LEU2 was 0.6 @ml and 1.3 ,uglml, respec- 
tively (Fig. 2A). The toxin-resistant growth of kre6A null 
mutant lines was much more obvious when cells were 
cultured in the osmotic stabilizing medium. In the me- 
dium containing 1 M sorbitol, 1 &ml HM-1 killer toxin 
was sufficient to kill the KRE6 cells, whereas 
kredA::LEU2 cells grew even in the presence of 
6pg/ml of HM-1 killer toxin (Fig. 2B). The above results 
demonstrated that functional KRE6 was required for the 
cytocidal action of HM-1 killer toxin. This was further 
confirmed by the re-introduction of the KRE6 gene into 
the kre6A::LEUZ lines. The 6.6 kb ClaI-BamHI frag- 
ment, which contains the entire KRE6 together with its 
Table 1 
Molar ratio of /Qlucans in KREd and kre6A:: LEV2 cells 
own promoter, was subcloned into pRS416, and 
kre6A::LEU2 cells were transformed with this 
plasmid. As pRS416 carried a centromeric replication 
origin, it was expected that one or two copies of the 
introduced KRE6 would be maintained in the cells. As 
expected, transformation with pRS-KRE6 rendered 
kre6A:: LEU2 cells sensitive to HM-1 killer tox- 
in; growth inhibition was observed in about 80% of the 
transformed cells with 2 &ml of HM-1 killer toxin (Fig. 
2B). 
Previously, it was demonstrated that disruption of 
KRE6 led to about a 50% reduction in j?-glucan content 
in the cell wall [l J. We also found that p-glucan synthase 
activity in kre6A:: LEU2 cells was about one-third of that 
in KRE6 cells. In addition, the introduction of intact 
KRE6 into kre6A:: LEU2 cells resulted in the recovery of 
the same level of B-glucan synthase activity as that de- 
tected in cells of the KRE6 lines (not shown). Changes 
in /?-glucan synthase activity caused by disruption or 
Alditol acetates Linkages Alkali-soluble glucan Alkali and acid- insoluble glucan 
2,3,4,6-Tetra-0-Me-Glc 
2,4,6-Tri-O-Me-Glc 
2,3,4-Tri-O-Me-Glc 
2,CDi-0-Me-Glc 
G’- 
.sG“ 
-6G1. 
d .gG I- 
.XGXG,. 
KRE6 kre6A:: LEV2 KRE6 kre6A:: LEU2 
1.1 1.2 1.1 1.0 
12.1 10.9 14.5 15.1 
3.3 1.9 2.0 1.3 
1.0 1.0 1.0 1.0 
3.7 5.7 7.3 11.6 
1 g of the fractionated /3-glucan from KRE6 and kre6A:: LEU2 cells was methylated, hydrolysed and acetylated. The partially methylated alditol 
acetates were analysed and the molar ratios of the glucose with indicated linkages are shown. 
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olo 0.2 0.4 0.6 0.6 IlO 1.2 114 
HM-1 concentration @g/ml) 
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0 341 
0 34l+KRE6 
. 342 
A 343 
A 344 
q 344+KRE6 
0 1 2 3 4 5 6 
HM-1 concentration (pglml) 
Fig. 2. Toxin resistant growth of kre6d null mutants. (A) Cells from the KRM lines (342 and 343) or kre6A:: LEU2 lines (341 and 344) were cultured 
in the presence of the indicated concentrations of HM-1 killer toxin. The population of the toxin-resistant cells is indicated as the 56 of the cell density 
without HM-1 killer toxin. (B) Cells from the KRM lines (342 and 343), kre6A::LEU2 lines (341 and 344) and kre6A:: LEU2 lines harboring 
pRS-KRE6 were cultured in the presence of the indicated concentrations of HM-1 killer toxin and 1 M sorbitol. The population of the toxin-resistant 
cells is indicated as the % of the cell density obtained without HM-1 killer toxin. 
re-introduction of KRE6 correlated to the loss or gain of cell wall between kre6A:: LEU2 cells and KRE6 cells 
the resistance to HM-1 killer toxin; cells with lower (about 400 pug per mg dry yeast in both strains). Further 
/I-glucan synthase activity became resistant o HM-1 kil- analysis revealed that, in both alkali-soluble and -insolu- 
ler toxin, whereas those with normal p-glucan synthase ble /3-glucan fractions, the molar ratio of p- 1,6-glucan in 
activity were still sensitive to this toxin. kre6A::LEU2 cells was less than two-thirds of that in 
There was little difference in the total polysaccharide KRE6 cells (Table 1). In kre6A::LEU2 cells, the molar 
content in alkali-soluble and -insoluble fractions of the ratio of /I- 1,3-glucan in the alkali-soluble /%glucan frac- 
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Fig. 3. Inhibition of HM-1 killer toxin action by polysaccharides. Cells of strain A451 were incubated with 3 &ml HM-1 killer toxin together with 
the indicated concentrations of polysaccharides for 3 h, and further cultured on YPD agar plates. The number of surviving cells is indicated as the 
% of the number of colonies that appeared without toxin treatment. 
tion was also reduced to some extent. However, the 
molar ratios of /&glucan with a reduced end and that 
with both /I- 1,3- and /3- 1 $-linkages were almost the same 
in these two lines, and this was true for both alkali- 
soluble and -insoluble /I-glucan fractions (Table I). 
These results indicate that the disruption of KRE6 leads 
to a more than 50% reduction of /I- 1,6-glucan content in 
the cell wall, and that the reduction of /3-l ,6-glucan con- 
tent is accompanied by the reduced sensitivity to HM-1 
killer toxin. Thus, it is speculated that HM-1 killer toxin 
interacts with cell wall /I-glucans, especially with /I-1,6- 
glucan, at the initial step of its action. 
In order to confirm the interaction of HM-I killer 
toxin with cell wall B-glucans, several oligosaccharides 
were prepared and their ability to neutralize the activity 
of HM-1 killer toxin was examined. Laminaran, a poly- 
mer of /& 1,3-glucan with /3- 1,6-linkage, strongly blocked 
the cytocidal action of HM-1 killer toxin at a concentra- 
tion of 2.5 mg/ml or higher. The /I-1,6-glucan polymer 
and short chains of /I-1,3-glucan were also effective in 
protecting cells from the cytocidal action of HM-1 killer 
toxin. /CGlucan was no longer active when cells were 
pretreated with HM-1 killer toxin for 3 h. Mannan 
showed a slight inhibitory activity of the HM-1 killer 
toxin, but chitin and starch (cl-1,Cglucan) did not block 
the cytocidal action of HM-1 killer toxin (Fig. 3). Thus, 
it appears that B-glucan is an essential cell wall compo- 
nent for the cytocidal activity of HM-1 killer toxin, and 
that this toxin attacks the yeast cells by recognizing cell 
wall /3glucans. 
4. Diicussion 
We have demonstrated that (i) the kre6A null mutant 
lines acquired resistance to HM-1 killer toxin, and that 
this resistance was accompanied by a reduced level of cell 
wall /?-1,6glucan content, and (ii) addition of a large 
excess of laminaran or /I-1,6-glucan polymer could neu- 
tralize the cytocidal action of HM-1 killer toxin. All these 
results strongly suggest hat HM-I killer toxin interacts 
with cell wall /?-glucans at the initial step for its action, 
and that this interaction is essential for the cytocidal 
action of HM-1 killer toxin. 
Disruption of KRE6 reduced the sensitivity to the 
toxin, but it did not result in strong resistance to the 
toxin when assayed in regular medium. Since disruption 
of the KRE6 gene just reduced /I-1,6-glucan levels and 
32 
did not result in the complete absence of /?-1,6-glucan, 
kre6A null mutants still harbored a certain amount of 
p-1,6-glucan. This may account for the small difference 
in sensitivity to the toxin between KRE6 and kre6A null 
mutant lines. More interestingly, the kre6A null mutant 
line, which still contained about 50% of the wild-type 
level of/3-1,6-glucan, showed the decreased sensitivity to 
the toxin. Since levels of the polysaccharides in the yeast 
cell wall are quite high, the above result suggests that a 
certain level of cell wall p-glucan is required to retain the 
normal sensitivity to the toxin, and that the toxin re- 
quires high concentrations of polysaccharide, in this 
case, /?-1,6-glucan, to interact. This may explain the rea- 
son why very high concentrations of p-glucan were nec- 
essary to block the cytocidal activity of HM-1 killer toxin 
in the competition assay. 
We have also generated radiolabelled HM-1 killer 
toxin to demonstrate the direct binding of HM-1 killer 
toxin to certain polysaccharides. However, the direct 
binding of the toxin to the cell wall components was not 
observed even with ‘*‘I- or 35S-labelled toxin. This may 
probably be due to the lower affinity of the toxin to the 
polysaccharide. Usually, affinities of proteins to polysac- 
charides are very low except for those to lectins. In fact, 
the direct binding of Kl killer toxin to its acceptor, /?- 1,6- 
glucan, also remains to be established in spite of the fact 
that Kl killer toxin has a much higher affinity to /I-1,6- 
glucan than HM-1 killer toxin (the concentration of 
/I-1,6-glucan required to block the action of Kl killer 
toxin is about 100 times less than that for HM-1 killer 
toxin) [6]. 
/I-1,3-Glucan and mannan also suppressed the action 
of HM-1 killer toxin, although they were not as effective as 
laminaran or /I-1,6-glucan. Because /I-1,3-glucan and 
mannan used in this study were highly purified materials, 
it is unlikely that contaminated /3-1,6-glucan in these 
fractions affected the HM-1 killer toxin activity. The 
mechanism of the suppression of the cytocidal action of 
HM-1 killer toxin by several cell wall components re- 
mains to be studied. However, it is conceivable that HM-I 
killer toxin recognizes the complex structure composed of 
several oligosaccharides which is similar to the cell wall 
structure, and that /3-1,6-glucan has the highest affinity 
to HM-1 killer toxin among these cell wall components. 
As reported by Roemer and Bussey [l], we also found 
that disruption of KRE6 significantly decreased the 
/I-glucan synthase activity. Since the major product of 
this in vitro enzyme assay was b-1,3-glucan (data not 
shown, and see [24]), it was rather surprising that the 
/?- 1,3-glucan content was not significantly affected by the 
S. Kasahara et al. IFEBS Letters 348 (1994) 27-J-7 
disruption of KRE6. Because in vitro B-1,6-glucan syn- 
thase assay has not been established, we do not know 
how /3-l ,6-glucan synthase activity was influenced by the 
disruption of KRE6. 
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